PMC:7781431 / 20830-21728 JSONTXT

Annnotations TAB JSON ListView MergeView

    LitCovid-PubTator

    {"project":"LitCovid-PubTator","denotations":[{"id":"614","span":{"begin":0,"end":4},"obj":"Gene"},{"id":"615","span":{"begin":235,"end":239},"obj":"Gene"},{"id":"616","span":{"begin":283,"end":287},"obj":"Gene"},{"id":"617","span":{"begin":379,"end":383},"obj":"Gene"},{"id":"618","span":{"begin":686,"end":690},"obj":"Gene"},{"id":"619","span":{"begin":741,"end":745},"obj":"Gene"},{"id":"620","span":{"begin":836,"end":841},"obj":"Gene"},{"id":"621","span":{"begin":469,"end":474},"obj":"Species"},{"id":"622","span":{"begin":85,"end":99},"obj":"Chemical"},{"id":"623","span":{"begin":119,"end":124},"obj":"Chemical"},{"id":"624","span":{"begin":395,"end":399},"obj":"Chemical"},{"id":"625","span":{"begin":453,"end":455},"obj":"Chemical"},{"id":"626","span":{"begin":634,"end":641},"obj":"Chemical"},{"id":"627","span":{"begin":857,"end":864},"obj":"Chemical"},{"id":"628","span":{"begin":754,"end":766},"obj":"Disease"},{"id":"629","span":{"begin":658,"end":664},"obj":"CellLine"}],"attributes":[{"id":"A614","pred":"tao:has_database_id","subj":"614","obj":"Gene:1241"},{"id":"A615","pred":"tao:has_database_id","subj":"615","obj":"Gene:1241"},{"id":"A616","pred":"tao:has_database_id","subj":"616","obj":"Gene:1241"},{"id":"A617","pred":"tao:has_database_id","subj":"617","obj":"Gene:1241"},{"id":"A618","pred":"tao:has_database_id","subj":"618","obj":"Gene:1241"},{"id":"A619","pred":"tao:has_database_id","subj":"619","obj":"Gene:1241"},{"id":"A620","pred":"tao:has_database_id","subj":"620","obj":"Gene:4790"},{"id":"A621","pred":"tao:has_database_id","subj":"621","obj":"Tax:9606"},{"id":"A622","pred":"tao:has_database_id","subj":"622","obj":"MESH:D007975"},{"id":"A623","pred":"tao:has_database_id","subj":"623","obj":"MESH:D008055"},{"id":"A625","pred":"tao:has_database_id","subj":"625","obj":"MESH:D014316"},{"id":"A626","pred":"tao:has_database_id","subj":"626","obj":"MESH:D002118"},{"id":"A627","pred":"tao:has_database_id","subj":"627","obj":"MESH:D002118"},{"id":"A628","pred":"tao:has_database_id","subj":"628","obj":"MESH:D007249"},{"id":"A629","pred":"tao:has_database_id","subj":"629","obj":"CVCL:0045"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"BLT1 has also been shown to be a receptor for RvE1 although its clone, high-affinity leukotriene B4 (LTB4) is a potent lipid inflammatory chemoattractant, inducing T helper cell chemotaxis and early effector T cell recruitment through BLT1 (Yokomizo et al. 1997; Arita et al. 2007). BLT1 shares 21% sequence identity with chemerin1; while this value is relatively low, selective BLT1 antagonist U-75,302 has been demonstrated to replace the binding of [3H]-RvE1 to the human PMN membrane (Arita et al. 2007). Besides, although RvE1 is 100 times less potent than LTB4, it inhibited adenylate cyclase activity and induced intracellular calcium mobilization in HEK293 cells overexpressing BLT1. These data indicate the role of RvE1 in reducing BLT1-induced inflammation by RvE1 acting as a partial agonist that competes with LTB4-mediated NF-κB activation and calcium mobilization (Arita et al. 2007)."}

    LitCovid-sentences

    {"project":"LitCovid-sentences","denotations":[{"id":"T209","span":{"begin":0,"end":256},"obj":"Sentence"},{"id":"T210","span":{"begin":257,"end":275},"obj":"Sentence"},{"id":"T211","span":{"begin":276,"end":282},"obj":"Sentence"},{"id":"T212","span":{"begin":283,"end":501},"obj":"Sentence"},{"id":"T213","span":{"begin":502,"end":508},"obj":"Sentence"},{"id":"T214","span":{"begin":509,"end":691},"obj":"Sentence"},{"id":"T215","span":{"begin":692,"end":891},"obj":"Sentence"},{"id":"T216","span":{"begin":892,"end":898},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"BLT1 has also been shown to be a receptor for RvE1 although its clone, high-affinity leukotriene B4 (LTB4) is a potent lipid inflammatory chemoattractant, inducing T helper cell chemotaxis and early effector T cell recruitment through BLT1 (Yokomizo et al. 1997; Arita et al. 2007). BLT1 shares 21% sequence identity with chemerin1; while this value is relatively low, selective BLT1 antagonist U-75,302 has been demonstrated to replace the binding of [3H]-RvE1 to the human PMN membrane (Arita et al. 2007). Besides, although RvE1 is 100 times less potent than LTB4, it inhibited adenylate cyclase activity and induced intracellular calcium mobilization in HEK293 cells overexpressing BLT1. These data indicate the role of RvE1 in reducing BLT1-induced inflammation by RvE1 acting as a partial agonist that competes with LTB4-mediated NF-κB activation and calcium mobilization (Arita et al. 2007)."}